TrialRheumatology (Oxford, England)2025

Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial.

Ai Kuzumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.